12 November 2024
12 November 2024 AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States AstraZeneca today announces $3.5 billion of capital investment in…
12 November 2024 Koselugo showed statistically significant and clinically meaningful objective response rate vs. placebo in adults with neurofibromatosis type 1 in global KOMET Phase…
AstraZeneca 12 November 2024 9M and Q3 2024 results Upgrade to full year 2024 guidance underpinned by strong underlying growth momentum Revenue and EPS…
12 November 2024 Concurrent Technologies Plc (the “Company” or the “Group”) $3.72m Systems contract secured with leading defence provider in Asia Concurrent Technologies Plc…
8 November 2024
Ocean Wilsons Holdings Limited (LSE: OCN) today announces its third quarter update for 2024. Ocean Wilsons Holdings Limited Quarterly Update – Q3 2024 Ocean…
Tezspire met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps Tezspire demonstrated a statistically significant and…
Scottish Mortgage Investment Trust PLC (“the Company”) Legal Entity Identifier: 213800G37DCS3Q9IJM38 Board Update The Board is pleased to announce the appointment of Christopher Samuel…
7 November 2024
John Pettigrew, Chief Executive, said: “Over the last six months, the exciting momentum within National Grid has continued as we deliver an unprecedented step…